Interaction studies between indomethacin nanocrystals and PEO/PPO copolymer stabilizers

Pharmaceutical Research

Volumn 32, Issue 2, 2015, Pages 628-639

  Liu, Peng ^a   Viitala, Tapani ^a   Kartal Hodzic, Alma ^a   Liang, Huamin ^a   Laaksonen, Timo ^a   Hirvonen, Jouni ^a   Peltonen, Leena ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Interaction studies; Nanocrystals; PEO PPO copolymer; Surface plasmon resonance (SPR); Wet ball milling

Indexed keywords

COPOLYMER; INDOMETACIN; INDOMETHACIN NANOCRYSTAL; NANOCRYSTAL; POLY(ETHYLENE OXIDE) POLY(PROPYLENE OXIDE) COPOLYMER; UNCLASSIFIED DRUG; EXCIPIENT; MACROGOL DERIVATIVE; NANOPARTICLE; PEO-PPO-PEO; POLYMER; PROPANEDIOL DERIVATIVE;

ARTICLE; CHEMICAL INTERACTION; CHEMICAL STRUCTURE; CONTACT ANGLE; DISSOLUTION; PARTICLE SIZE; PRIORITY JOURNAL; STABILIZER DRUG INTERACTION; STATIC ELECTRICITY; SURFACE PLASMON RESONANCE; ZETA POTENTIAL; CHEMISTRY; DRUG INTERACTION; METABOLISM; PROCEDURES;

DRUG INTERACTIONS; EXCIPIENTS; INDOMETHACIN; NANOPARTICLES; POLYETHYLENE GLYCOLS; POLYMERS; PROPYLENE GLYCOLS; SURFACE PLASMON RESONANCE;

EID: 84921458310     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-014-1491-3     Document Type: Article

References (43)

1. Rabinow BE. Nanosuspensions in drug delivery. Nat Rev Drug Discov. 2004;3:785-96.
2. Müller RH, Gohla S, Keck CM. State of the art of nanocrystals - special features, production, nanotoxicology aspects and intracellular delivery. Eur J Pharm Biopharm. 2011;78(1):1-9.
3. Moschwitzer JP. Drug nanocrystals in the commercial pharmaceutical development process. Int J Pharm. 2013;453(1):142-56.
4. Shegokar R, Müller RH. Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives. Int J Pharm. 2010;399(1-2):129-39.
5. Lindfors L, Forssen S, Westergren J, Olsson U. Nucleation and crystal growth in supersaturated solutions of a model drug. J Colloid Interf Sci. 2008;325(2):404-13.
6. Lee J, Choi JY, Park CH. Characteristics of polymers enabling nanocomminution of water-insoluble drugs. Int J Pharm. 2008;355(1-2):328-36.
7. Lai F, Sinico C, Ennas G, Marongiu F, Marongiu G, Fadda AM. Diclofenac nanosuspensions: influence of preparation procedure and crystal formon drug dissolution behaviour. Int J Pharm. 2009;373(1-2):124-32.
8. Xiong R, Lu W, Li J, Wang P, Xu R, Chen T. Preparation and characterization of intravenously injectable nimodipine nanosuspension. Int J Pharm. 2008;350(1-2):338-43.
9. Douroumis D, Fahr A. Stable carbamazepine colloidal systems using the cosolvent technique. Eur J Pharm Sci. 2007;30(5):367-74.
10. Cerdeira AM, Mazzotti M, Gander B. Miconazole nanosuspensions: influence of formulation variables on particle size reduction and physical stability. Int J Pharm. 2010;396(1-2):210-8.
11. Dolenc A, Kristl J, Baumgartner S, Planinsek O. Advantages of celecoxib nanosuspension formulation and transformation into tablets. Int J Pharm. 2009;376:204-12.
12. Mauludin R, Müller RH, Keck CM. Development of an oral rutin nanocrystal formulation. Int J Pharm. 2009;370:202-9.
13. Mauludin R, Müller RH, Keck CM. Kinetic solubility and dissolution velocity of rutin nanocrystals. Eur J Pharm Sci. 2009;36:502-10.
14. Guo Y, Luo J, Tan S, Otieno BO, Zhang Z. The applications of vitamin E TPGS in drug delivery. Eur J Pharm Sci. 2013;49:175-86.
15. Peltonen L, Hirvonen J. Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods. J Pharm Pharmacol. 2010;62:1569-79.
16. Van Eerdenbrugh B, Vermant J, Martens JA, Froyen L, Van Humbeeck J, Augustijns P, et al. A screening study of surface stabilization during the production of drug nanocrystals. J Pharm Sci. 2009;98(6):2091-103.
17. Sepassi S, Goodwin DJ, Drake AF, Holland S, Leonard G, Martini L, et al. Effect of polymer molecular weight on the production of drug nanoparticles. J Pharm Sci. 2007;96(10):2655-66.
18. Lee J, Lee SJ, Choi JY, Yoo JY, Ahn CH. Amphiphilic amino acid copolymers as stabilizers for the preparation of nanocrystal dispersion. Eur J Pharm Sci. 2005;24(5):441-9.
19. Lee MK, Kim S, Ahn CH, Lee J. Hydrophilic and hydrophobic amino acid copolymers for nano-comminution of poorly soluble drugs. Int J Pharm. 2010;384:173-80.
20. Moghimi SM, Hunter AC. Poloxamers and poloxamines in nanoparticle engineering and experimental medicine. Trends Biotechnol. 2000;18(10):412-20.
21. Alvarez-Lorenzo C, Sosnik A, Concheiro A. PEO-PPO block copolymers for passive micellar targeting and overcoming multidrug resistance in cancer therapy. Curr Drug Targets. 2011;12(8):1112-30.
22. Alvarez-Lorenzo C, Rey-Rico A, Sosnik A, Taboada P, Concheiro A. Poloxamine-based nanomaterials for drug delivery. Front biosci (Elite ed). 2010;2:424-40.
23. Chiappetta DA, Sosnik A. Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: Improved hydrosolubility, stability and bioavailability of drugs. Eur J Pharm Biopharm. 2007;66(3):303-17.
24. Knoll W. http://www2.mpip-mainz.mpg.de/groups/knoll/software.
25. Liu P, De Wulf O, Laru J, Heikkilä T, Van Veen B, Kiesvaara J, et al. Dissolution studies of poorly soluble drug nanosuspensions in non-sink conditions. AAPS PharmSciTech. 2013;14:748-56.
26. Pardeike J, Müller RH. Nanosuspensions: a promising formulation for the new phospholipase A(2) inhibitor PX-18. Int J Pharm. 2010;391:322-9.
27. Pardeike J, Strohmeier DM, Schröedl N, Voura C, Gruber M, Khinast JC, et al. Nanosuspensions as advanced printing ink for accurate dosing of poorly soluble drugs in personalized medicines. Int J Pharm. 2011;420(1):93-100.
28. Watanabe A. A trial production of a table of the optical crystallographic characteristics of crystalline drugs including crystal habits (study of crystalline drugs by means of a polarizing microscope. XIX Yakugaku zasshi. 2002;122(8):595-606.
29. Love JC, Estroff LA, Kriebel JK, Nuzzo RG, Whitesides GM. Self-assembled monolayers of thiolates on metals as a form of nanotechnology. Chem Rev. 2005;105(4):1103-69.
30. Gustafsson SS, Vrang L, Terelius Y, Danielson UH. Quantification of interactions between drug leads and serum proteins by use of "binding efficiency". Anal Biochem. 2011;409(2):163-75.
31. Mende S, Stenger F, Peukert W, Schwedes J. Mechanical production and stabilization of submicron particles in stirred media mills. Powder Technol. 2003;132:64-73.
32. Sezgin Z, Yüksel N, Baykara T. Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs. Eur J Pharm Biopharm. 2006;64(3):261-8.
33. Bilgili E, Afolabi A. A combined microhydrodynamics-polymer adsorption analysis for elucidation of the roles of stabilizers in wet stirred media milling. Int J Pharm. 2012;439:193-206.
34. Alvarez-Lorenzo C, Gonzalez-Lopez J, Fernandez-Tarrio M, Sandez-Macho I, Concheiro A. Tetronic micellization, gelation and drug solubilization: Influence of pH and ionic strength. Eur J Pharm Biopharm. 2007;66(2):244-52.
35. Liu P, Rong X, Laru J, Van Veen B, Kiesvaara J, Hirvonen J, et al. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling. Int J Pharm. 2011;411:215-22.
36. Chaubal MV, Popescu C. Conversion of nanosuspensions into dry powders by spray drying: a case study. Pharm Res. 2008;25(10):2302-8.
37. Verma S, Kumar S, Gokhale R, Burgess DJ. Physical stability of nanosuspensions: investigation of the role of stabilizers on Ostwald ripening. Int J Pharm. 2011;406:145-52.
38. Sarkar B, Venugopal V, Tsianou M, Alexandridis P. Adsorption of pluronic block copolymers on silica nanoparticles. Colloid Surf A. 2013;422:155-64.
39. Bergaya F, Lagaly G. Developments in Clay Science. Oxford: Elsevier; 2012.
40. Goodwin DJ, Sepassi S, King SM, Holland SJ, Martini LG, Lawrence MJ. Characterization of polymer adsorption onto drug nanoparticles using depletion measurements and small-angle neutron scattering. Mol Pharm. 2013;10:4146-58.
41. Malmsten M, Linse P, Cosgrove T. Adsorption of PEO-PPO-PEO block copolymers at silica. Macromolecules. 1992;25:2474-81.
42. Lambert O, Jada A, Dumas P. Adsorption of triarm starblock copolymers based on polystyrene, poly(ethylene oxide) and poly(ecaprolactone) at the solid-solution interface. Colloid Surf A. 1998;136:263-72.
43. Jain TK, Erokwu B, Dimitrijevic S, Flask CA, Labhasetwar V. Magnetic resonance imaging of multifunctional pluronic stabilized iron-oxide nanoparticles in tumor-bearing mice. Biomaterials. 2009;30(35):6748-56.